Atlas Trials

Small Lymphocytic Lymphoma With 17p Deletion

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Small Lymphocytic Lymphoma With 17p Deletion

RecordFirmDate
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion (NCT01744691)Pharmacyclics LLC.2013-01-01

Track Small Lymphocytic Lymphoma With 17p Deletion automatically

Every clearance here is in the API, with alerts when new ones post.